China Emerges as Leading Competitor in Humanoid Robot Workforce Integration Says Tesla CEO Kaiko CEO Outlines Vision for EventsDriven Contract Infrastructure in Crypto Markets SpaceX and OpenAI IPOs Could Amplify AI Valuation Concerns Analysts Suggest USChina Trade Divergence Persists After TrumpXi Summit Phillies Homegrown Sluggers Reunion Hint Sparks Speculation on Team Valuation and Revenue Potential Strait of Hormuz Tanker Attack Highlights Geopolitical Risks for Global Oil Shipping KNTK Q1 2026 Earnings Significant EPS Miss as Company Posts Surprise Loss INR Q1 2026 Earnings Massive EPS Beat Driven by Operational Efficiency Norfolk Southern Q1 2026 Earnings Rail Operator Beats EPS Estimates Amid Operational Resilience AZZ Inc Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Execution Toast Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher DAR Q1 2026 Earnings EPS Surges Past Estimates with 459 Beat Celularity CELU Edges Higher Navigating Key Resistance at 097 Nathans Famous NATH Holds Near 101 as RangeBound Trading Persists Acco Brands ACCO Gains 25 as Stock Holds Above Key Support International General Insurance Holdings IGIC Faces Resistance Slips 266 on Lower Volume Wave Life Sciences WVE Nears Support After Modest Decline Spain Blocks Access to Prediction Markets Kalshi and Polymarket Over Gambling Law Concerns LSPD Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Execution Progress Invesco Municipal Income Opportunities Trust OIA Rallies 131 as YieldSeeking Investors Return Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting Sea Limited SE Q1 2026 Earnings EPS Misses Estimates Amid Competitive Pressures Boston Scientific Q1 2026 Earnings EPS Beats Street by 069 Shares Edge Higher NXGL Q1 2026 Earnings LargerThanExpected Loss Weighs on Shares ATYR Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline Without Revenue GDEV Q4 2025 Earnings EPS Misses Estimates as Stock Declines NRIX Q1 2026 Earnings EPS Miss as DevelopmentStage Biotech Advances Pipeline